Thomas Grogan
Pediatric Orthopaedic Surgery Los Angeles, CA Medical Doctor
NPI 1134260110 CMS profile 367151
11710 Wilshire Blvd, Los Angeles, CA 90025
General payments
$328
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Thomas Grogan of Los Angeles, CA is reported in the CMS Open Payments database as having received $328 across 12 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 23rd percentile of Pediatric Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $48 | 2 | |
| 2024 | General | $152 | 2 | |
| 2023 | General | $18 | 1 | |
| 2022 | General | $23 | 1 | |
| 2021 | General | $49 | 3 | |
| 2020 | General | $15 | 1 | |
| 2019 | General | $23 | 2 |
Beside peers
- Thomas Grogan
- Pediatric Orthopaedic Surgery median
- Middle half of Pediatric Orthopaedic Surgery
- National median
In program year 2025, general payments to Thomas Grogan were reported at $48. Among 495 Pediatric Orthopaedic Surgery profiles paid that year, the median was $271 and the middle half received between $89 and $1,158.
Show as a table
| Year | Thomas Grogan | Pediatric Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $23 | $355 | $117–$1,889 | $163 |
| 2020 | $15 | $290 | $62–$1,625 | $114 |
| 2021 | $49 | $628 | $75–$2,400 | $132 |
| 2022 | $23 | $427 | $115–$2,170 | $149 |
| 2023 | $18 | $265 | $98–$1,497 | $160 |
| 2024 | $152 | $255 | $84–$1,694 | $164 |
| 2025 | $48 | $271 | $89–$1,158 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
38
Drug cost
$284
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Methylprednisolone | Generic | 38 | $284 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,233 Part D prescribers listed as Orthopaedic Surgery; they describe a distribution and say nothing about conduct.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Orthopaedic Surgery in California
Robert Cho
Pediatric Orthopaedic Surgery · Beverly Hills, CA
Jeffrey Kanel
Pediatric Orthopaedic Surgery · Los Gatos, CA
Michael Kimball
Pediatric Orthopaedic Surgery · San Diego, CA
Lindsay Andras
Pediatric Orthopaedic Surgery · Los Angeles, CA
Selina Poon
Pediatric Orthopaedic Surgery · Pasadena, CA
Vedant Kulkarni
Pediatric Orthopaedic Surgery · Sacramento, CA
Related records
Pediatric Orthopaedic Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.